August 7, 2023 (Earnings Report) Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Eli Lilly & Co
Symbol: LLY
Recent Price: $449.49
Average Analyst Price Target: $360.82 (13.47%)
Market Cap: $426.69B
Last Year's EPS: 2.09
Consensus EPS Forecast: 1.73
Expected Earnings Date: 2023-04-27
Recent Analyst Action: Evan Seigerman, analyst at BMO Capital, reiterates coverage on Eli Lilly & Co (LLY) in the Healthcare sector with a Buy rating and a price target of $565 (1 week ago).
TipRanks.com also reports that Eli Lilly & Co currently has 20 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $360.82 . The target pricing ranges from a high forecast of $455.00 down to a low forecast of $236.00. Eli Lilly & Co (LLY)’s last closing price was $449.49 which would put the average price target at 13.47% upside.Here are 3rd party ratings for LLY:
Recent Analyst Action: Michael Ryskin, analyst at Bank of America Securities, reiterates coverage on Zoetis (ZTS) in the Healthcare sector with a Buy rating and a price target of $200 (1 week ago).
TipRanks.com also reports that Zoetis currently has 12 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $239.25 . The target pricing ranges from a high forecast of $254.00 down to a low forecast of $225.00. Zoetis (ZTS)’s last closing price was $178.63 which would put the average price target at 17.94% upside.Here are 3rd party ratings for ZTS:
Recent Analyst Action: Joanne Wuensch, analyst at Citi, reiterates coverage on Insulet (PODD) in the Healthcare sector with a Hold rating and a price target of $319 (4 weeks ago).
TipRanks.com also reports that Insulet currently has 14 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $309.58 . The target pricing ranges from a high forecast of $350.00 down to a low forecast of $250.00. Insulet (PODD)’s last closing price was $263.14 which would put the average price target at 29.66% upside.Here are 3rd party ratings for PODD:
Recent Analyst Action: Benjamin Nolan, analyst at Stifel Nicolaus, reiterates coverage on New Fortress Energy (NFE) in the Energy sector with a Buy rating and a price target of $49 (5 days ago).
TipRanks.com also reports that New Fortress Energy currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $56.00 . The target pricing ranges from a high forecast of $68.00 down to a low forecast of $44.00. New Fortress Energy (NFE)’s last closing price was $28.23 which would put the average price target at 49.49% upside.Here are 3rd party ratings for NFE:
Recent Analyst Action: Itay Michaeli, analyst at Citi, reiterates coverage on Luminar Technologies (LAZR) in the Technology sector with a Buy rating and a price target of $18 (2 months ago).
TipRanks.com also reports that Luminar Technologies currently has 14 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $16.00 . The target pricing ranges from a high forecast of $21.00 down to a low forecast of $8.00. Luminar Technologies (LAZR)’s last closing price was $7 which would put the average price target at 85.71% upside.Here are 3rd party ratings for LAZR:
Recent Analyst Action: Unknown Analyst, analyst at Northland Securities, reiterates coverage on Payoneer (PAYO) in the Financial sector with a Buy rating and a price target of $10 (3 weeks ago).
TipRanks.com also reports that Payoneer currently has 13 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $7.83 . The target pricing ranges from a high forecast of $10.00 down to a low forecast of $6.50. Payoneer (PAYO)’s last closing price was $4.92 which would put the average price target at 78.86% upside.Here are 3rd party ratings for PAYO:
Recent Analyst Action: Matthew Biegler, analyst at Oppenheimer, reiterates coverage on Arvinas Holding Company (ARVN) in the Healthcare sector with a Buy rating and a price target of $95 (1 month ago).
TipRanks.com also reports that Arvinas Holding Company currently has 12 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $82.50 . The target pricing ranges from a high forecast of $123.00 down to a low forecast of $49.00. Arvinas Holding Company (ARVN)’s last closing price was $24.02 which would put the average price target at 199.75% upside.Here are 3rd party ratings for ARVN:
To Your Financial Future,
The Editor, WallStreetSectors.com